PRHUB strengthens its healthcare and biosciences business with 3 new mandate wins
PRHUB will be handling the mandates of Medall Diagnostics, Transasia Bio-Medicals and Aum Biosciences
Published - 15-April-2019
PRHUB, the independent, full-service PR and communication firms, has announced three wins in the healthcare & biosciences space – Medall Diagnostics, India’s 4th largest diagnostics chain serving 9 million customers, Transasia Bio-Medicals, India’s leading in-vitro diagnostic company and Singapore-based Aum Biosciences, one of a kind oncology-focused biotech venture leading the innovation of affordable oncology therapeutics out of Asia. These wins and the subsequent strengthening of its healthcare practice marks PRHUB as among the few firms in India with deep expertise across education, healthcare, manufacturing, engineering, automotive, utilities, technology, consumer and internet verticals.
The mandates include brand consulting and social media marketing alongside media relations reinforcing its credentials as a new-age, integrated communication firm. The Singapore win also marks a first, opening a new market to expand. PRHUB has a successful record in handling clients across the healthcare spectrum - Motherhood, Sankara Eyecare, Nobel Biocare, Vascular Concepts, Dr. Batra’s, Dr. Health, Ayurvaid, Stemade, Perfint, Star Clinics, Cellworks, Xcode, etc. in the past. It now services clients out of 7 cities in India besides Singapore beyond India.
Commenting on the wins, Xavier Prabhu, Founder & Managing Director, PRHUB, said, “Healthcare and biosciences require careful, calibrated and consistent brand communication. Am truly delighted that these leading brands placed their confidence in us to do so and look forward to delivering successful custom communication campaigns for each of them. More wins in the healthcare space are in the offing, which will position us as among the goto partners for healthcare firms of all hues, in the Indian market.”
“We have a growing network in Singapore where we are speaking to many emerging ventures who are evaluating us for new age communication solutions beyond traditional media relations,” he further added.
In his comments, Raju Venkatraman, Founder & CEO, Medall Healthcare Pvt. Ltd., said,” We were seeking a partner who brought a clear understanding of the unique situation we are in, fresh strategic clarity on how to use communication to solve certain challenges and the expertise to deliver. PRHUB did well on all these parameters. We look forward to working with their team closely as Medall embarks on an exponential growth journey in the year ahead.”
According to Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd.,” We were quite finicky about our choice of a PR partner and it was for the exact reason we waited for 2 long years almost before finalizing on PRHUB. They understood our business & needs quickly, were flexible to our exacting requirements and demonstrated their execution capability as well with the first-ever press conference we did recently. We wish them well and look forward to their sustained contribution as TransAsia seeks to further build on its leadership position as India’s leading IVD player.”
Explaining the rationale for engaging with PRHUB, Vishal Doshi, Founder & CEO, AUM Biosciences, said,” We are a unique venture that is seeking to transform how niche oncology therapeutic innovation are developed from Asia to Global. A complex business model in a niche area and a global impact, meant you need a partner who navigates multiple elements well. We were also looking for someone who would help with the brand repositioning and communication of key messages to audiences globally. We are looking forward towards a successful collaboration with PR HUB.”For more updates, be socially connected with us on
WhatsApp, Instagram,LinkedIn, Twitter, Facebook & Youtube